Name Net increased
positions
Increased positions Reduced positions Return since
30 Jun ‘16
226
38 185 147 49.5%
227
38 101 63 875%
228
38 132 94 6.2%
REGN icon
229
Regeneron Pharmaceuticals
REGN
$82.8B
37 222 185 126%
230
37 63 26 237%
231
37 137 100 290%
232
37 89 52 53.4%
233
37 74 37 63%
234
37 77 40 30.3%
235
37 113 76 248%
COO icon
236
Cooper Companies
COO
$16.3B
37 154 117 94.4%
237
37 145 108 44.9%
238
37 49 12 240%
239
36 242 206 55.8%
240
36 96 60 233%
241
36 134 98 47.6%
242
36 127 91 446%
243
36 219 183 314%
244
36 120 84 358%
245
36 49 13 564%
246
36 190 154 12.5%
247
36 81 45 86.6%
248
36 40 4 20%
249
36 49 13 57.8%
250
36 44 8 98.9%